SCHEMBL23937826

SCHEMBL23937826

Cn1c(=O)n(O)c2cnccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.46
FEN1 P39748 3/20 0.43
ERCC1 P07992 1/20 0.43
ERCC4 Q92889 1/20 0.43
GABRA5 P31644 1/20 0.38
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
TGFBR1 P36897 1/20 0.36
ATM Q13315 1/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
BCL6 P41182 1/20 0.35
KDM4E B2RXH2 1/20 0.35
BRD4 O60885 1/20 0.35
BRPF1 P55201 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674016 0.93 DAO (0.46) DAOFEN1ERCC1ERCC4GABRA5
SCHEMBL12251818 0.84 PDE3B (0.44) DAOGABRA5PDE3BPDE3ACYP1A2
SCHEMBL31425940 0.84 PDE3B (0.44) DAOGABRA5PDE3BPDE3ACYP1A2
SCHEMBL12060489 0.75 KDM5A (0.46) GABRA5CYP1A2TGFBR1ALDH1A1BCL6
SCHEMBL13322656 0.75 HPD (0.42) DAOGABRA5PDE3BPDE3ACYP1A2
SCHEMBL12049021 0.75 HPD (0.42) DAOGABRA5PDE3BPDE3ACYP1A2
SCHEMBL1520214 0.74 ERCC1 (0.66) FEN1ERCC1ERCC4CYP1A2ALDH1A1
SCHEMBL23470178 0.73 PGR (0.51) GABRA5CYP1A2ATMADORA3ALDH1A1
SCHEMBL13322657 0.71 MAPK14 (0.40) DAOPDE3BPDE3ACYP1A2CYP3A4
SCHEMBL9534299 0.70 ADORA3 (0.49) FEN1ERCC1ERCC4PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3399968-B1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS PHARMATECH LTD (KY) 2021-10-20 EP disclosed